Short term use of a hybrid closed loop system might preferentially benefit people with type 1 diabetes who have impaired awareness of hypoglycaemia (IAH), Australian research suggests. In a pilot study of 16 patients aged 12 – 55 years, participants crossed between eight weeks of standard insulin pump therapy (control period) and eight weeks using ...
Type 1 diabetes
Hybrid Closed Loop insulin delivery system has potential to restore hypoglycaemia awareness
By Mardi Chapman
19 Feb 2021